You are here
Binosto (Alendronate Sodium) Available in U.S. for Treatment of Osteoporosis
Although osteoporosis is often thought of as a disease that affects mostly women, the disorder also occurs in men. While women experience relatively rapid bone loss in the first few years after menopause, by about age 65, men and women lose bone mass at the same rate. Osteoporosis affects more than 200 million women and men worldwide and more than 10 million people in the U.S.
Binosto is a once-weekly, strawberry-flavored effervescent tablet containing alendronate sodium (70 mg) that rapidly dissolves in half a glass (4 oz) of room-temperature water to make a buffered solution. The product is available in packs of four.
For more information, visit the Mission Pharmacal Company Web site.